Search

Copyright of Experientia is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The indication for the use of mydriatics in the treatment of dosed-angle glaucoma are discussed. The value of their use consists in the elimination of pupillary block and in an antiphlogistic action. This claimed that these effects prevent the formation of posterior and peripheral anterior synechiae and thus prevent the condition from becoming chronic.

Propranololum reduces the intraocular tension by inhibiting the production of aqueous humour. In about 50% of all cases the medicament, given as 1% drops, proves an effective anti-glaucomatous agent. Combined with adrenaline it is particularly effective and well tolerated.

By reducing the concentration of hypotensive drops and increasing the number of instillations, a therapeutic effect similar to that of the concentrated drop can be obtained, with a reduction of side-effects. The results of experiments with pilocarpine, adrenaline-guanethidine combination and propranolol are described.